Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics-related AEs While Receiving Fluoropyrimidine or Irinotecan Therapy
Clinical trial NCT05583422 · COMPLETED
Trial details
- NCT number
- NCT05583422
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-08-18
- Primary completion
- 2024-06-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.